NVS vs REGN
Novartis AG Common Stock · Regeneron Pharmaceuticals, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | NVS | REGN |
|---|---|---|
| Price | $162.55 | $904.35 |
| Market Cap | $310.17B | $85.38B |
| P/E | 22.18 | 18.95 |
| P/B | 6.72 | 2.55 |
| P/S | — | 5.95 |
| ROE | 30.3% | 13.4% |
| Net Margin | — | 31.4% |
| Gross Margin | — | — |
| Revenue Growth | — | 1.0% |
| Dividend Yield | — | — |
| EPS | $7.33 | $47.72 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.